Sun-Ranbaxy are keen to complete the merger process.
Car makers have started hiring from Gujarat's industrial training institutes (ITIs) for their factories across the country.
.jpg)
In a letter to health minister Harsh Vardhan, the Indian Pharmaceutical Alliance, an industry body representing leading pharma companies, including Sun Pharma, Lupin, Dr Reddy's Labs, Cadila Health and Glenmark, stressed the need for an out-of-court settlement with health activists fighting for the rights of clinical trial participants.
The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
The company did not respond to specific queries on the project's expansion.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.
Honda has invested Rs 3,526 crore in its Rajasthan unit.
The NPPA letter was issued to GSK on Wednesday.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
.jpg)
What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
Maruti Suzuki is keen that the Gujrat government revises payment condition in the agreement it signed with the former for setting up a plant in Hansalpur.
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
CCI has accused realty player DLF of preparing one-sided agreement with home buyers
Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances